NanoGroup S.A. Logo

NanoGroup S.A.

Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.

NNG | WAR

Overview

Corporate Details

ISIN(s):
PLNNGRP00011 (+3 more)
LEI:
259400HXWEAZUWRLY648
Country:
Poland
Address:
Warszawa Rakowiecka 36, 02-532 Warszawa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NanoGroup S.A. is a biotechnology company that develops and commercializes innovative medical solutions based on its unique, patented nanotechnology. The group's research and development work is concentrated on addressing critical medical needs, primarily in the fields of oncology and transplantology. Key projects include the development of nanoformulations for anticancer drugs, a fluid for the storage of organs intended for transplantation, nanoparticles for diagnostics and therapy, and a human blood substitute. The company operates through specialized subsidiaries, such as nanoSanguis and nanoVelos, to advance its distinct technological platforms and bring new medical technologies to market.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-27 17:16
Quarterly Report
Raport 2025Q3
Polish 1.1 MB
2025-11-27 17:10
Quarterly Report
Raport 2025Q3
Polish 1.1 MB
2025-11-21 08:55
Regulatory Filings
Strategia 2026-2028
Polish 2.1 MB
2025-11-21 08:55
Management Reports
Strategia Rozwoju NanoGroup S.A. na lata 2026-2028 - Content (PL)
Polish 2.6 KB
2025-11-17 12:46
Share Issue/Capital Change
Inwestycja pośrednia w AUXILIUS PHARMA S.A. - Content (PL)
Polish 4.8 KB
2025-11-10 17:02
Share Issue/Capital Change
Dopuszczenie i wprowadzenie do obrotu giełdowego Akcji Serii K - Content (PL)
Polish 1.4 KB
2025-11-03 19:31
Registration Form
Oświadczenie KDPW
Polish 176.7 KB
2025-11-03 19:31
Share Issue/Capital Change
Rejestracja w Krajowym Depozycie Papierów Wartościowych akcji serii K - Content…
Polish 1.6 KB
2025-10-14 13:02
Registration Form
Statut
Polish 1.5 MB
2025-10-14 13:02
Registration Form
Rejestracja zmian statutu - Content (PL)
Polish 5.1 KB
2025-10-08 16:18
Board/Management Information
Oświadczenie
Polish 156.9 KB
2025-10-08 16:18
Board/Management Information
Oświadczenie
Polish 131.2 KB
2025-10-08 16:18
Board/Management Information
Powołanie osób nadzorujących - członków Rady Nadzorczej drugiej kadencji - Cont…
Polish 1.3 KB
2025-10-08 16:04
Board/Management Information
Rezygnacja Członka Rady Nadzorczej - Content (PL)
Polish 508 bytes
2025-10-08 15:53
Declaration of Voting Results & Voting Rights Announcements
Lista akcjonariuszy
Polish 51.0 KB

Automate Your Workflow. Get a real-time feed of all NanoGroup S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NanoGroup S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NanoGroup S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Halychpharm Logo
A pharmaceutical manufacturer of finished medicines and plant-derived phytochemical substances.
Ukraine
GFARM
HANALL BIOPHARMA CO.,LTD Logo
Develops innovative medicines for chronic diseases through antibody and small molecule research.
South Korea
009420
Hana Pharm. Co., Ltd. Logo
Pharmaceutical firm specializing in anesthetics and narcotic analgesics for global markets.
South Korea
293480
Hanmi Pharm. Co., Ltd. Logo
Biopharma firm developing innovative diabetes and cancer drugs for patients and professionals.
South Korea
128940
Hansa Biopharma Logo
Develops antibody-cleaving enzymes to treat rare diseases and enable organ transplants.
Sweden
HNSA
Harmony Biosciences Holdings, Inc. Logo
Develops innovative therapies for rare neurological diseases, focusing on conditions like narcolepsy.
United States of America
HRMY
HARROW, INC. Logo
Develops branded ophthalmic therapies and custom compounded solutions for North American eyecare.
United States of America
HROW
HCW Biologics Inc. Logo
Developing novel immunotherapies to treat aging-related chronic inflammation.
United States of America
HCWB
HEALIOS K.K. Logo
Develops iPS and somatic stem cell therapies for diseases like ARDS and cancer.
Japan
4593
Heartseed株式会社 Logo
Develops iPSC-derived cell therapies to regenerate heart tissue for heart failure.
Japan
219A

Talk to a Data Expert

Have a question? We'll get back to you promptly.